GeminIQ Website Logo

Viewing REVB free

Subscribe for full history, 90+ metrics, screener, watchlist...

REVELATION BIOSCIENCES, INC.

REVB

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
11141113546712151214
Prepaid Expense And Other Assets Current
000000000000
Deferred Offering Costs
------00000-
Assets Current
12141113547712151214
Property Plant And Equipment Net
000000000000
Operating Lease Right Of Use Asset
111---0-----
Other Assets Noncurrent
000---0-----
Assets
12151213547712151214
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
111111131211
Accrued Liabilities Current
101110118111
Operating Lease Liability Current
000---0-----
Liabilities Current
2122212411565
Operating Lease Liability Noncurrent
111---0-----
Liabilities
2232212411565
Stockholders Equity
Common Stock Value
000000000000
Additional Paid In Capital
666558584945454138383232
Retained Earnings Accumulated Deficit
-56-52-49-47-45-43-41-39-37-28-25-23
Stockholders Equity
101391143531979
Liabilities And Stockholders Equity
12151213547712151214
Preferred Stock Par Or Stated Value Per Share
----------0.0010.001
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
500500500500500500500500500500500500
Common Stock Shares Issued
442100000000
Shares Outstanding
442100000000

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20267.35%-3.92%3.92%---------
2025-72.54%-75.48%-68.98%15.97%-39.92%-46.64%-5.45%-14.85%-36.04%-10.53%-13.91%-26.39%
2024-6.31%-7.28%-22.82%15.00%-11.50%-16.50%-7.32%-56.22%-70.00%-21.97%-15.61%-29.77%
2023----10.00%-8.13%-23.07%30.36%-14.07%-43.59%-12.24%-13.08%-7.17%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
6.21
10.02
5.41
6.92
3.42
3.61
3.43
1.64
1.10
2.80
2.18
2.62
Quick Ratio
6.11
9.96
5.36
6.85
3.30
3.40
3.40
1.61
1.08
2.78
2.17
2.59
Working Capital
9.80M
12.79M
8.81M
10.98M
3.79M
2.84M
4.65M
2.59M
1.07M
9.40M
6.58M
8.75M
Leverage & Debt
Debt to Equity
0.24
0.16
0.31
0.17
0.41
0.38
0.41
1.52
9.76
0.55
0.84
0.61
Debt Ratio
0.19
0.14
0.23
0.14
0.29
0.27
0.29
0.60
0.91
0.36
0.46
0.38
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Diluted EPS TTM
-4.29
-4.85
-14.36
-12.29
-42.17
-178.00
-1,052.16
-1,111.60
-1,867.21
-6,317.22
-404.08
2,541.49
Free Cash Flow Per Share TTM
-2.35
-2.73
-13.32
-11.00
-74.65
-226.50
-1,287.10
-1,191.61
-1,063.24
-6,040.44
-24,483.49
-18,096.75
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
94.17%
7.95%
-40.73%
-47.61%
-46.78%
60.79%
12,405.64%
-1,873.10%
-781.72%
-560.43%
-98.89%
-106.49%
EPS Growth (1Y)
-89.82%
-97.28%
-98.64%
-98.89%
-97.74%
-97.18%
160.38%
-143.74%
-125.88%
-157.16%
-99.65%
-115.02%
Valuation Metrics
P/E TTM
-0.24
-0.25
-0.22
-0.46
-0.21
-0.18
-0.08
-0.15
-0.20
-0.08
-7.14
1.56
P/B TTM
0.39
0.30
0.22
0.34
0.47
0.89
0.27
0.85
2.74
0.08
0.13
0.15
Market Cap
3.94M
3.85M
1.99M
3.76M
1.81M
2.55M
1.27M
2.28M
3.12M
746.24K
858.80K
1.37M
Enterprise Value
-7.54M
-10.26M
-8.71M
-8.95M
-3.37M
-1.15M
-5.23M
-4.26M
-8.95M
-13.81M
-11.13M
-12.63M
Calculated Values
Free Cash Flow TTM
-9.01M
-8.76M
-8.27M
-7.27M
-14.98M
-18.33M
-18.40M
-16.63M
-9.06M
-8.57M
-7.29M
-6.23M
Net Debt
-11.48M
-14.11M
-10.70M
-12.71M
-5.17M
-3.70M
-6.50M
-6.54M
-12.07M
-14.55M
-11.99M
-13.99M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2023-12-08Sale
Owner: Tidmarsh, George F
Title: -
Shares: 27,771
Price/Share: $0.52
Value: $14,440.92
Shares Owned: -
Relationship: Director
Ownership: Direct
2023-10-16Sale
Owner: Tidmarsh, George F
Title: -
Shares: 1,845
Price/Share: $0.65
Value: $1,199.25
Shares Owned: 27,771
Relationship: Director
Ownership: Direct
2023-09-28Sale
Owner: Tidmarsh, George F
Title: -
Shares: 1,429
Price/Share: $0.69
Value: $986.01
Shares Owned: 42,096
Relationship: Director
Ownership: Indirect
2023-09-18Sale
Owner: Tidmarsh, George F
Title: -
Shares: 4,000
Price/Share: $0.74
Value: $2,960.00
Shares Owned: 39,348
Relationship: Director
Ownership: Direct
2023-04-18Purchase
Owner: Tidmarsh, George F
Title: -
Shares: 25,000
Price/Share: $1.16
Value: $29,000.00
Shares Owned: 64,848
Relationship: Director
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
15.58%
Inst. Shares: 499,670
Shares Outstanding: 3,207,720
2025-12-31
195.76%
Inst. Shares: 1,215,239
Shares Outstanding: 620,785
2025-09-30
14.37%
Inst. Shares: 380,097
Shares Outstanding: 2,644,733
2025-06-30
10.60%
Inst. Shares: 85,050
Shares Outstanding: 802,670
2025-03-31
5.61%
Inst. Shares: 4,538
Shares Outstanding: 80,943

REVELATION BIOSCIENCES, INC. (REVB) — SEC Financial Statements & Analysis

REVELATION BIOSCIENCES, INC. (REVB) is a pharmaceutical preparations company, incorporated in DE. REVELATION BIOSCIENCES, INC. trades on Nasdaq as: REVB, REVBW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), REVELATION BIOSCIENCES, INC. reported a Debt-to-Equity ratio of 0.24x, a Price-to-Book (P/B) ratio of 0.39x (TTM), at a market cap of $3.94M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
0.24x
P/B TTM
0.39x
Market Cap
$3.94M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is REVELATION BIOSCIENCES, INC. in?

REVELATION BIOSCIENCES, INC. (REVB) operates in the Pharmaceutical Preparations industry.

What is REVB's market cap?

REVELATION BIOSCIENCES, INC. (REVB) has a market capitalization of $3.94M as of 2026-06-30.

What exchange does REVB trade on?

REVELATION BIOSCIENCES, INC. (REVB) trades on the Nasdaq.

Where is REVELATION BIOSCIENCES, INC. incorporated?

REVELATION BIOSCIENCES, INC. is incorporated in DE.

Wall Street's data.
Main Street's price.